BMY : Summary for Bristol-Myers Squibb Company Co - Yahoo Finance

U.S. Markets close in 3 hrs 19 mins

Bristol-Myers Squibb Company (BMY)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
56.09+0.05 (+0.09%)
As of 12:41PM EDT. Market open.
People also watch
MRKLLYABTPFEJNJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close56.04
Open56.04
Bid0.00 x
Ask0.00 x
Day's Range55.95 - 56.36
52 Week Range46.01 - 77.12
Volume2,684,118
Avg. Volume13,181,901
Market Cap93.82B
Beta0.96
PE Ratio (TTM)21.17
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.56 (2.79%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com1 hour ago

    [$$] Could Pfizer Make Cash Bid for Bristol-Myers?

    Credit Suisse One of the most common topics of discussion in our investor meetings remains the question around whether Pfizer or another biopharma company may be interested in acquiring Bristol-Myers Squibb in the next nine-12 months, given some of the challenges Bristol-Myers is facing and the activist involvement in the name. To supplement our previous work, our HOLT [proprietary Credit Suisse platform] colleagues have now taken a look at the possibility of Pfizer buying Bristol-Myers from a HOLT perspective and do see the deal as providing an opportunity for value-creation.

  • Business Wire6 hours ago

    Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute Announce Collaboration to Accelerate Immuno-Oncology Research

    The Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb Company and the Cancer Research Institute today announced a multi-year clinical research collaboration to coordinate and rapidly initiate clinical Immuno-Oncology studies across the Parker Institute and CRI networks.

  • TheStreet.com18 hours ago

    Warren, Democrats Write Icahn About Advising Trump

    Sen. Elizabeth Warren and six other lawmakers sent a letter to the billionaire corporate-raider turned activist arguing that he may be breaking federal conflict of interest laws.